Adjuvant methotrexate (MTX) escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas

R. Rentschler, G. Chonkich, G. Petti

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)C-766
JournalProceedings of the American Society of Clinical Oncology
VolumeVol. 1
StatePublished - 1982

ASJC Scopus Subject Areas

  • General Medicine

Cite this